Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Myfortic in Fed vs Fasting Renal Transplant Patients
NCT00585468Phase 4Completed
- Sponsor
- University of Utah
- Start
- Dec 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate sodium in kidney transplant rejection (2 arms), sponsored by University of Utah. Primary endpoints: Maximum Observed Plasma Concentration of Mycophenolic Acid, Minimum Observed Plasma Concentration of Mycophenolic Acid and 6 more. Started Dec 2007; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00585468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585468.